The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution.
作者信息
Puig N, Conde I, Jiménez C, Sarasquete M E, Balanzategui A, Alcoceba M, Quintero J, Chillón M C, Sebastián E, Corral R, Marín L, Gutiérrez N C, Mateos M-V, González-Díaz M, San-Miguel J F, García-Sanz R
机构信息
1] Department of Hematology, University Hospital of Salamanca, Salamanca, Spain [2] IBSAL, Salamanca, Spain [3] IBMCC (USAL-CSIC), Salamanca, Spain.
Department of Hematology, Hospital Miguel Servet, Zaragoza, Spain.
出版信息
Leukemia. 2015 Jun;29(6):1435-7. doi: 10.1038/leu.2015.7. Epub 2015 Jan 8.
PMID:25567133
Abstract
摘要
Zotero 插件